MedPath

Post-Operative Therapy for Nausea or Vomiting

Phase 4
Terminated
Conditions
Vomiting
Nausea
Interventions
Procedure: Acupressure
Registration Number
NCT03075163
Lead Sponsor
University of California, Davis
Brief Summary

This is a single site, prospective, randomized controlled study designed to evaluate the impact of acupressure when used as an initial treatment before rescue medications in the treatment of post-operative nausea and/or vomiting at UCD.

Detailed Description

Each individual will only participate in the post anesthetic care unit starting from when the patient's nurse or anesthesiology team deems that the patient needs treatment for PONV. It ends when the patient is discharged from anesthesiology care.

Patients will be asked to score nausea before randomized treatment of acupressure or medication, and to score nausea after treatment.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Patients scheduled for elective surgery requiring general anesthesia
Exclusion Criteria
  • Age less than 18 years
  • Adults unable to give primary consent
  • Pregnancy
  • Prisoners
  • Unable to access pericardial 6 acupressure point bilaterally post procedure
  • Allergy to Ondansetron

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AcupressureAcupressureManual pressure will be applied on the wrists bilaterally.
OndansetronOndansetronOndansetron (Zofran) is used for the treatment of nausea and vomiting.
Primary Outcome Measures
NameTimeMethod
Change in Nausea ScoreTime to discharge from post anesthetic care unit

Difference in the nausea score before and after treatment. Nausea is scored on a scale from 1 to 10 with 1 being no nausea and 10 being severe nausea with impending vomiting.

A greater difference is indicative of a better outcome

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UC Davis Health

🇺🇸

Sacramento, California, United States

© Copyright 2025. All Rights Reserved by MedPath